Pfizer Fellow, Arrupe Research Fellow
Department of Pharmaceutical and Health Care Marketing
St. Joseph’s University
Dr. Thani Jambulingam is a Professor in the Department of Pharmaceutical and Healthcare Marketing at St. Joseph’s University (SJU), Erivan K. Haub School of Business, in Philadelphia, Pennsylvania, USA. Dr. Jambulingam teaches both in the Pharmaceutical & Healthcare MBA program and in the Pharmaceutical and Healthcare Marketing undergraduate program. He has served as the chair of the Department for 8 years and launched the first EMBA online program at SJU in 2002. He is trained in case method for teaching at Harvard University. Before his Ph.D., Dr. Jambulingam worked in the commercial of the pharmaceutical industry for several years. He then took his Ph.D. at the University of Wisconsin, Madison, USA.
Dr. Jambulingam’s research interests are in pharmaceutical and healthcare marketing strategy. His work has been published in several refereed academic journals and trade publications in marketing and management. Dr. Jambulingam has served as the external reader for Ph.D. dissertations at Columbia University.
Dr. Jambulingam is a visiting Professor for the Wharton MBA program in their global programs in India. He is also a faculty at the Biotechnology Entrepreneurship Bootcamp held every year during the BIO International Convention. He has served as a consultant and facilitated educational training sessions in strategy for senior leadership and/or brand teams within several small, mid and large pharmaceutical firms and healthcare systems in the US.
As a Pfizer fellow, Dr. Jambulingan spent a year at Pfizer with the Prevnar Global Commercial Team contributing to developing healthy aging platform development, franchise positioning, vaccine business strategy for emerging markets, and pediatric expanded age expansion strategy (life cycle management). He conducted strategy sessions for executive leadership within the specialty care division of Pfizer. He also served as a mentor to several CEOs of start-up companies. Dr. Jambulingam has received several excellence awards in teaching and research at SJU. He was inducted into Rho Chi, the honor society for pharmacy and Beta Gama Sigma, the honor society for business. Dr. Jambulingam serves on the advisory board of two startup biotech/pharma companies and one went IPO in 2021. Also in 2021, Dr. Jambulingam received the prestigious Tangelmann Award for lifetime contribution to the excellence in teaching and outstanding commitment to research at SJU.